Article
Antiandrogens Continue to Be Focus of Nonmetastatic CRPC Treatment
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Atish D. Choudhury, MD, PhD, sheds light on the nonmetastatic castration-resistant prostate cancer treatment landscape and notable ongoing trials examining antiandrogens in different settings.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value